These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
543 related articles for article (PubMed ID: 27865627)
1. Epidemiology of infections caused by polymyxin-resistant pathogens. Giamarellou H Int J Antimicrob Agents; 2016 Dec; 48(6):614-621. PubMed ID: 27865627 [TBL] [Abstract][Full Text] [Related]
2. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018. Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925 [TBL] [Abstract][Full Text] [Related]
3. The rise and spread of Nang SC; Li J; Velkov T Crit Rev Microbiol; 2019 Mar; 45(2):131-161. PubMed ID: 31122100 [TBL] [Abstract][Full Text] [Related]
4. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in Daly SM; Sturge CR; Felder-Scott CF; Geller BL; Greenberg DE mBio; 2017 Nov; 8(6):. PubMed ID: 29114023 [TBL] [Abstract][Full Text] [Related]
5. Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteria. Barker WT; Martin SE; Chandler CE; Nguyen TV; Harris TL; Goodell C; Melander RJ; Doi Y; Ernst RK; Melander C Bioorg Med Chem; 2017 Oct; 25(20):5749-5753. PubMed ID: 28958847 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of polymyxin resistance: knowns and unknowns. Baron S; Hadjadj L; Rolain JM; Olaitan AO Int J Antimicrob Agents; 2016 Dec; 48(6):583-591. PubMed ID: 27524102 [TBL] [Abstract][Full Text] [Related]
8. Detection of colistin-resistant Gram-negative rods by using the SuperPolymyxin medium. Jayol A; Poirel L; André C; Dubois V; Nordmann P Diagn Microbiol Infect Dis; 2018 Oct; 92(2):95-101. PubMed ID: 29885757 [TBL] [Abstract][Full Text] [Related]
9. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria. Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435 [TBL] [Abstract][Full Text] [Related]
10. Structural Modification of Lipopolysaccharide Conferred by Liu YY; Chandler CE; Leung LM; McElheny CL; Mettus RT; Shanks RMQ; Liu JH; Goodlett DR; Ernst RK; Doi Y Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373195 [No Abstract] [Full Text] [Related]
11. Colistin: still a lifesaver for the 21st century? Karaiskos I; Souli M; Galani I; Giamarellou H Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):59-71. PubMed ID: 27573251 [TBL] [Abstract][Full Text] [Related]
12. How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? Al-Tawfiq JA; Laxminarayan R; Mendelson M Int J Infect Dis; 2017 Jan; 54():77-84. PubMed ID: 27915108 [TBL] [Abstract][Full Text] [Related]
13. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Liu YY; Wang Y; Walsh TR; Yi LX; Zhang R; Spencer J; Doi Y; Tian G; Dong B; Huang X; Yu LF; Gu D; Ren H; Chen X; Lv L; He D; Zhou H; Liang Z; Liu JH; Shen J Lancet Infect Dis; 2016 Feb; 16(2):161-8. PubMed ID: 26603172 [TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant Gram-negative infections: what are the treatment options? Giamarellou H; Poulakou G Drugs; 2009 Oct; 69(14):1879-901. PubMed ID: 19747006 [TBL] [Abstract][Full Text] [Related]
16. Cross-resistance to human cationic antimicrobial peptides and to polymyxins mediated by the plasmid-encoded MCR-1? Dobias J; Poirel L; Nordmann P Clin Microbiol Infect; 2017 Sep; 23(9):676.e1-676.e5. PubMed ID: 28344161 [TBL] [Abstract][Full Text] [Related]
17. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria. Nastro M; Rodríguez CH; Monge R; Zintgraff J; Neira L; Rebollo M; Vay C; Famiglietti A J Chemother; 2014 Aug; 26(4):211-6. PubMed ID: 24070502 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of polymyxin resistance and detection of mcr genes. Mlynarcik P; Kolar M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):28-38. PubMed ID: 30439931 [TBL] [Abstract][Full Text] [Related]
19. [Results of a multicenter study investigating plasmid mediated colistin resistance genes (mcr-1 and mcr-2) in clinical Enterobacteriaceae ısolates from Turkey]. Sarı AN; Süzük S; Karatuna O; Öğünç D; Karakoç AE; Çizmeci Z; Alışkan HE; Cömert F; Bakıcı MZ; Akpolat N; Çilli FF; Zer Y; Karataş A; Akgün Karapınar B; Bayramoğlu G; Özdamar M; Kalem F; Delialioğlu N; Aktaş E; Yılmaz N; Gürcan Ş; Gülay Z Mikrobiyol Bul; 2017 Jul; 51(3):299-303. PubMed ID: 28929967 [TBL] [Abstract][Full Text] [Related]
20. Resistance to polymyxins in Gram-negative organisms. Jeannot K; Bolard A; Plésiat P Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]